Proteomics

Dataset Information

0

Dapansutrile preserves pancreatic beta-cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis


ABSTRACT: DAPA improved pancreatic beta-cell function in diabetic mice by inhibiting NLRP3-Caspase-1 signaling, enhancing insulin vesicle fusion, and modulating mitochondrial homeostasis, indicating its potential as a novel treatment for diabetes.

ORGANISM(S): Mus Musculus

SUBMITTER: Jiaqiang Zhou  

PROVIDER: PXD054615 | iProX | Tue Aug 06 00:00:00 BST 2024

REPOSITORIES: iProX

altmetric image

Publications

Dapansutrile preserves pancreatic beta-cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis.

Wu Ying Y   Fu Hongxing H   Zhu Min M   Yao Yuanfa Y   Jin Luhong L   Lin Xihua X   Zhou Jiaqiang J  

Diabetes, obesity & metabolism 20260128


<h4>Aims/hypothesis</h4>Pancreatic beta-cell dysfunction is pivotal in diabetes pathogenesis, with the NOD-like receptor protein 3 (NLRP3) inflammasome playing a crucial role. Dapansutrile (DAPA), a novel NLRP3 inhibitor, demonstrates promise in diabetes management.<h4>Methods</h4>The diabetic model of high-fat diet (HFD) + streptozotocin (STZ) mice was utilized to assess glucose metabolism indicators following DAPA intervention. Experiments involving pancreatic islets from normal mice or humans  ...[more]

Similar Datasets

2011-08-20 | E-GEOD-25205 | biostudies-arrayexpress
2011-08-21 | GSE25205 | GEO
2024-04-16 | GSE262867 | GEO
2016-08-17 | GSE85706 | GEO
| S-EPMC9044128 | biostudies-literature
| PRJNA1132960 | ENA
2024-12-05 | PXD055718 | Pride
| PRJNA669991 | ENA
2023-05-10 | GSE202648 | GEO
2016-06-30 | E-GEOD-70123 | biostudies-arrayexpress